Hikma Injectables USA Inc recalls ketamine inj 50 mg per 1 mL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
- Products
-
- ketamine inj 50 mg per 1 mL
- Company
- Hikma Injectables USA Inc
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 1,800 syringes
- About this recall
- ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25